bioAffinity Technologies, Inc. Shareholders' Equity
bioAffinity Technologies, Inc. (BIAF) had Shareholders' Equity of $3.77 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $3.77M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.65M; Stockholders' Equity Attributable to Parent as first filed $3.66M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.28M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $8.90M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $3.77M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $3.65M 10-Q · filed 2026-08-07 | $3.66M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $7.28M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $8.90M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$2.14M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $1.44M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $2.60M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $3.12M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $3.43M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $5.26M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $4.86M 10-K · filed 2026-03-16 | |
| 2023-09-30 | $6.99M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $8.10M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $9.67M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $11.04M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $12.60M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$16.79M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | -$16.72M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | -$15.79M 10-K · filed 2024-04-01 | |
| 2021-09-30 | -$15.69M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$14.16M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$15.07M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |